Cargando…

Convalescent plasma therapy for persistent hepatitis E virus infection

Detalles Bibliográficos
Autores principales:	Ankcorn, Michael, Gallacher, Jennifer, Ijaz, Samreen, Taha, Yusri, Harvala, Heli, Maclennan, Sheila, Thomson, Emma C., Davis, Chris, Singer, Joshua B., da Silva Filipe, Ana, Smollett, Katherine, Niebel, Marc, Semple, Malcolm G., Tedder, Richard S., McPherson, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126959/ https://www.ncbi.nlm.nih.gov/pubmed/31075322 http://dx.doi.org/10.1016/j.jhep.2019.04.008

Ejemplares similares

Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
por: Gallacher, Jennifer, et al.
Publicado: (2023)

Response to: ‘Chronic genotype 1 hepatitis E infection from immunosuppression for ileo-colonic Crohn’s disease’
por: Ankcorn, Michael, et al.
Publicado: (2019)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020
por: Harvala, Heli, et al.
Publicado: (2020)

Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening
por: Harvala, Heli, et al.
Publicado: (2019)

Variability and pathogenicity of hepatitis E virus genotype 3 variants
por: Smith, Donald B., et al.
Publicado: (2015)

Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England
por: Gates, Shannah, et al.
Publicado: (2023)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
por: Shankar-Hari, Manu, et al.
Publicado: (2020)

Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020
por: Mehew, Jennifer, et al.
Publicado: (2020)

Non-A Hepatitis B Virus Genotypes in Antenatal Clinics, United Kingdom
por: Dervisevic, Samir, et al.
Publicado: (2007)

Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization
por: Harvala, Heli, et al.
Publicado: (2022)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019
por: Harvala, Heli, et al.
Publicado: (2022)

Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma
por: Nguyen, Dung, et al.
Publicado: (2021)

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
por: Harvala, Heli, et al.
Publicado: (2020)

The Prevention and Treatment of Some Obscure Conditions Complicating Convalescence after Gastro-Enterostomy
por: MacLennan, Alex.
Publicado: (1916)

Comparison of SARS‐CoV‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study
por: Harvala, Heli, et al.
Publicado: (2021)

Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections
por: Harvala, Heli, et al.
Publicado: (2022)

Persistence of Zika virus in conjunctival fluid of convalescence patients
por: Tan, Jeslin J. L., et al.
Publicado: (2017)

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
por: Nurmi, Visa, et al.
Publicado: (2023)

Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit?
por: Simmonds, Peter, et al.
Publicado: (2020)

Plague Convalescence Period. Analysis of 108 Cases
por: Thomson, G. S.
Publicado: (1898)

Alterations in T and B cell function persist in convalescent COVID-19 patients
por: Shuwa, Halima A., et al.
Publicado: (2021)

Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19
por: Hocini, Hakim, et al.
Publicado: (2023)

Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity
por: Gaunt, Eleanor, et al.
Publicado: (2015)

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
por: Arabi, Yaseen M., et al.
Publicado: (2016)

Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020
por: Harvala, Heli, et al.
Publicado: (2022)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
por: Hocini, Hakim, et al.
Publicado: (2023)

Hepatitis E Virus Seroprevalence among Men Who Have Sex with Men, United Kingdom
por: Payne, Brendan A.I., et al.
Publicado: (2013)

The Role of Sudanese Doctors in the United Kingdom in Mitigating COVID-19 Vaccine Hesitancy Among Their Diaspora Communities
por: Hashim, Ahmed, et al.
Publicado: (2023)

T-Regulatory Cells and Inflammatory and Inhibitory Cytokines in Malawian Children Residing in an Area of High and an Area of Low Malaria Transmission During Acute Uncomplicated Malaria and in Convalescence
por: Nyirenda, Tonney S., et al.
Publicado: (2015)

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle
por: Smethurst, Katherine, et al.
Publicado: (2021)

Taking cues from convalescence to improve vaccines against hepatitis C virus
por: Sreekumar, Bharath K., et al.
Publicado: (2022)

Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020
por: Bubba, Laura, et al.
Publicado: (2021)

Convalescents
Publicado: (1907)

Convalescence
Publicado: (1875)

Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection
por: Dunham, C Michael, et al.
Publicado: (2003)

Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
por: Chioh, Florence WJ, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ea6bsr9o587s2mhm70soajllsf